Nutrient Intake, Apolipoprotein A5 -1131T>C Polymorphism and Its Relationship with Obesity

1st Annual Applied Science and Engineering Conference

工业技术;自然科学

Sari, M.I.^1 ; Sari, D.I.^2

Departement of Biochemistry, Faculty of Medicine, Sumatera Utara University, Jl. Dr. Mansur Kampus, Medan

20155, Indonesia^1

Departemen of Clinical Pathology, Faculty of Medicine, Sumatera Utara University, Medan, Jl. Dr. Mansur Kampus, Medan

20155, Indonesia^2

关键词: Anthropometric variables;    Apolipoproteins;    Body mass index;    Chi-square tests;    Cross-sectional study;    Environmental factors;    Gene variants;    World Health Organization;   

Others  :  https://iopscience.iop.org/article/10.1088/1757-899X/180/1/012094/pdf
DOI  :  10.1088/1757-899X/180/1/012094

来源: IOP

【 摘 要 】

Obesity is associated with the development of some of the most prevalent diseases of modern society. The World Health Organization estimates that at least 2.8 million adult die each year as result of being obesity. Nutrient intake is a key environmental factor that may interact with genotype to affect risk of obesity. The aim of study was assess the relation between nutrient intake and apolipoprotein A5 -1131T>C polimorphism with obesity. A cross sectional study has been carried out on 139 subjects. Nutrient intake data was collected by using a 24 hour dietary recall and analyzed by nutrisurvey software. Anthropometric variables were measured and body mass index (BMI). Apolipoprotein A5 -1131T>C polymorphism was visualized with 5% agarose gel after restriction length fragment polymorphism (RFLP) digested with MseI. Results : Subjects in this study were 55 male and 84 female, with average age 19.20 ± 1.08, 75 had obese and 64 non obese. Based on the chi square test is found a relationship between total energy intake and protein intake in obese group compared to the non-obese group (p = 0.029, p = 0.006) and no relationship was found in Apolipoprotein A5 -1131T> C polymorphism with obesity. These findings indicate that nutrient intake no depending with apolipoprotein A5 gene variant to modulate obesity.